BASS XXIII Tutorials and Keynote Address presentations:
| Session | Speaker | Presentation |
| Keynote Address | Janet Wittes | Learning from Extroverts, or Assuming Statistical Leadership |
| M-2 | Kao-Tai Tsai | Joint Modeling of Time-to-and Laboratory Test Data Trial |
| M-3 | Richard Zink | Uncovering Fraud, Misconduct and Other Data Quality Issues in Clinical Trials |
| M-4 | Vance Berger | Comparable comparison Groups in Randomized Clinical Trials |
| M-5 | Dungang Liu | Meta-analysis of Rare Events in Drug Safety Studies: A Unifying Framework for Exact Inference |
| M-6 | Gheorghe Doros | Clinical Trial Designs for Placebo Response in Clinical Trials for Psychiatric Disorders |
| M-7 | William R. Prucka | Innovative Designs and Analyses for Pediatric Drug Development |
| Keynote Address | Ralph B. D'Agostino, Sr. | Comments and Reflections on Issues in Clinical Trials:Both Design and Analysis:Past, Present and Future |
| T-2 | Bohdana Ratitch | Analysis Strategies for Clinical Trials with Treatment Non-Adherence |
| T-3 | Gerhardt Pohl, Anthony Zagar | Real World Evidence-Generalizability and Propensity Scoring |
| T-4 | Mat D. Davis | Current and Future States of the DIA Bayesian Scientific Working Group Education Effort |
| T-5 | Shankar Srinivasan, Vatsala Karwe | Tepee Plots: A Novel Statistical Descriptive Graphical Technique for Representating Tabular Data |
| T-6 | Steven Gilbert, Zorayr Manukyan | Bayesian Dynamic Borrowing |
| W-1 | Yi Ysong and Meiyu Shen | Analytical Biosimilar Assessment: Current Practice and Draft Guidance, Three Biosimilar Advisory Committee Meetings & Analytical Biosimilar Assessment: Frequently Discussed Statistical Issues |
| W-2 | ShanMei Liao, Bo Jin, Yi Tsong, Meiyu Shen and Cassie(Xiaoyu) Dong | Tipping Point Analysis- Considerations for Missing Data in Biosimilars & Biosimilars |
